Filing Details
- Accession Number:
- 0001615219-20-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-18 16:48:00
- Reporting Period:
- 2020-02-18
- Accepted Time:
- 2020-02-18 16:48:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1615219 | Salarius Pharmaceuticals Inc. | SLRX | Pharmaceutical Preparations (2834) | 465087339 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769747 | Scott Jordan | C/O Salarius Pharmaceuticals, Inc. 2450 Holcome Blvd., Suite J-608 Houston TX 77021 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-18 | 11,300 | $0.90 | 31,609 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 2,538 shares of unvested Common Stock which will become fully vested on June 30, 2020.